Edition:
India

Ra Pharmaceuticals Inc (RARX.OQ)

RARX.OQ on NASDAQ Stock Exchange Global Market

14.04USD
20 Nov 2017
Change (% chg)

$-0.23 (-1.61%)
Prev Close
$14.27
Open
$14.33
Day's High
$14.33
Day's Low
$13.92
Volume
34,305
Avg. Vol
45,424
52-wk High
$27.77
52-wk Low
$12.04

Select another date:

Fri, Nov 10 2017

BRIEF-Ra Pharmaceuticals posts Q3 loss of $0.68 per share

* Ra pharmaceuticals reports third quarter 2017 financial results and provides corporate update

BRIEF-Ra Pharmaceuticals files for mixed shelf offering of up to $250 million

* Ra Pharmaceuticals Inc files for mixed shelf offering of up to $250 million - SEC filing‍​ Source text: (http://bit.ly/2A6uuro) Further company coverage:

BRIEF-Ra Pharmaceuticals reports Q2 loss per share $0.56

* Ra Pharmaceuticals reports second quarter 2017 financial results and provides corporate update

BRIEF-RA Pharmaceuticals receives orphan drug designation from FDA for RA101495 for the treatment of paroxysmal nocturnal hemoglobinuria

* RA Pharmaceuticals receives orphan drug designation from the U.S. FDA for RA101495 for the treatment of paroxysmal nocturnal hemoglobinuria

BRIEF-Ra Pharmaceuticals announces data from phase 2 clinical trial of RA101495

* Ra Pharmaceuticals announces initial data from phase 2 clinical trial of RA101495 in Pnh

Select another date: